Alere India showcases latest range of Alere’s hematology solutions

FDA approved, Alere h 560, will cater to all the main requirements of the modern hematology laboratory using advanced technology to separate out abnormal cells populations through non – hazardous non cyanide reagents


Medical experts from all over India, hematologists, pathologists, microbiologists, endocrinologists, diabetologists, cardiologists, general physicians and other medical experts, gathered at the 54th annual conference of Indian Society of Hematology and Blood Transfusion.

Alere India, a subsidiary of the US-Based Alere Inc., a leading provider of near-patient diagnostics and health information solutions, launched its latest range of hematology solution, Alere h 560. Dr. M B Agarwal, country's leading hematologist launched Alere h 560 at the conference. The key feature of Alere h 560 is that it provides complete 5 part differential counts with 24 parameters and 2 scattergrams and 2 histograms. Compact, Ergonomically designed Alere h 560 caters to all the main requirements of the modern hematology laboratory.

Alere has forayed into both the major segments of hematology machines, namely 3 PD and 5 PD analyzer. The Alere h 380 is a 3 part differential analyzer, which has very effective processing speed of 80 samples/hr and has been developed keeping in minds the requirements for start-up to middle workload labs. Alere h 560 or 5 part differential system will cater to the requirement of bigger labs and chains and has more reportable parameters and features.

In India, diagnostic powerhouse Alere has been catering to the Infectious Disease Tests, Cardio-vascular range, toxicology/DOA range of products and women healthcare range and is now diversifying and entering into new segments as well. In India it is already representing Tosch for Immunoassay, Helena for electrophoresis and coagulation range. The company is now making a foray in hematology segment. This will enable Alere to become a true solution provider from hospitals, labs, near patient diagnosis.


Previous 1 Next
2 Comment Comment 1 - 1 of 1

VENKATESH 2 August 2015 at 01:57 PM



Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box


GST: Boon or Bane for Healthcare?

Send this article by email